OR WAIT null SECS
December 23, 2024
Article
A study shows that a lower non-HDL/HDL cholesterol ratio is linked to greater anemia prevalence. A threshold of 4.28 shows a 15% anemia risk drop per unit increase below this value.
Concizumab marks the first subcutaneous injection treatment for hemophilia A or B with inhibitors, demonstrating an 86% reduction in bleeds in pivotal trial data.
December 22, 2024
Video
Iron deficiency is currently screened at a ferritin threshold of 15 ug/mL, well below an accepted 25 ug/mL threshold.
December 20, 2024
The ATEV therapy, named Symvess, provides revascularization when autologous vein graft or implantation of a synthetic graft is not feasible.
December 19, 2024
Weisinger discussed findings from the largest cohort of patients with iTTP treated with Obinutuzumab.
December 18, 2024
A hematologist discusses the role of internal and family medicine practitioners in improving the diagnosis and management of iron deficiency.
Steven Fein, MD, discusses news and updates in sickle cell disease following ASH 2024.
In this video, a hematologist discusses trials and areas of advancement he is excited about in the current landscape.
In part 2 of our 5-part series, Steven Fein, MD, discusses updates in iron deficiency management from 2024.
In this video, Steven Fein, MD, discusses updates and topics of note from the American Society of Hematology annual meeting.